Evidence map›Paper›PMID 39318626›Full record

ArticleFrontiers in immunology2024

Case report: Breaking CNS immuno-privilege: TNFα-inhibitor triggers aseptic meningitis in a patient with rheumatoid arthritis.

Benedetta Kassabian, Monica Facco, Alessandro Miscioscia, Samuela Carraro, Francesca Rinaldi, Paolo Gallo, Marco Puthenparampil

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Benedetta KassabianNeurology Unit, Department of Neuroscience (DNS), Università degli Studi di Padova, Padua, Italy.
Monica FaccoLaboratory of Hematology and Immunology, Department of Medicine (DIMED), Università degli Studi di Padova, Padua, Italy.
Alessandro MisciosciaNeurology Unit, Department of Neuroscience (DNS), Università degli Studi di Padova, Padua, Italy.
Samuela CarraroLaboratory of Hematology and Immunology, Department of Medicine (DIMED), Università degli Studi di Padova, Padua, Italy.
Francesca RinaldiMultiple Sclerosis Centre, Neurology Unit, Azienda Ospedaliera di Padova, Padua, Italy.
Paolo GalloNeurology Unit, Department of Neuroscience (DNS), Università degli Studi di Padova, Padua, Italy.
Marco PuthenparampilNeurology Unit, Department of Neuroscience (DNS), Università degli Studi di Padova, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood-brain barrier dysfunction might be driven by peripheral inflammation. TNFα inhibitors (TNF-α

Indexed as

Arthritis, RheumatoidEtanerceptMeningitis, AsepticTumor Necrosis Factor-alphaAntirheumatic AgentsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyTumor Necrosis Factor InhibitorsAntirheumatic AgentsEtanerceptTumor Necrosis Factor-alphaTumor Necrosis Factor Inhibitorsaseptic meningitisblood-brain barriercerebrospinal fluidetanerceptPET-MRIrheumatoid arteritis

Identifiers

PMID39318626
PMCPMC11420026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.